CINECA IRIS Institutional Research Information System

SCHIRINZI, ERIKA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.646
AS - Asia 862
EU - Europa 508
SA - Sud America 153
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.238
Salva come PNG Salva come JPEG
Nazione #
CA - Canada 2.319
US - Stati Uniti d'America 1.310
SG - Singapore 301
CN - Cina 221
IT - Italia 178
BR - Brasile 131
HK - Hong Kong 128
SE - Svezia 80
VN - Vietnam 78
DE - Germania 54
FR - Francia 42
CI - Costa d'Avorio 29
GB - Regno Unito 27
BG - Bulgaria 26
FI - Finlandia 25
AT - Austria 19
IN - India 19
JP - Giappone 19
RU - Federazione Russa 17
BD - Bangladesh 14
TR - Turchia 14
KR - Corea 12
MX - Messico 9
MA - Marocco 8
NL - Olanda 8
PL - Polonia 8
AR - Argentina 7
ID - Indonesia 7
PK - Pakistan 7
ZA - Sudafrica 7
SN - Senegal 6
UA - Ucraina 5
CH - Svizzera 4
EC - Ecuador 4
EG - Egitto 4
NG - Nigeria 4
NP - Nepal 4
PH - Filippine 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CL - Cile 3
ES - Italia 3
IQ - Iraq 3
IR - Iran 3
KZ - Kazakistan 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
BE - Belgio 2
DZ - Algeria 2
IL - Israele 2
KE - Kenya 2
LY - Libia 2
MY - Malesia 2
NI - Nicaragua 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
TN - Tunisia 2
VE - Venezuela 2
AM - Armenia 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LK - Sri Lanka 1
NO - Norvegia 1
OM - Oman 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
Totale 5.238
Salva come PNG Salva come JPEG
Città #
Montreal 2.307
Ashburn 186
Singapore 178
Dallas 169
Hong Kong 128
Santa Clara 97
San Jose 94
Fairfield 62
Chandler 60
Beijing 55
Shanghai 51
Los Angeles 42
Seattle 38
Milan 37
Woodbridge 37
Houston 34
Cambridge 32
New York 32
Munich 30
Abidjan 29
Sofia 25
Florence 24
Ann Arbor 22
Boardman 22
Wilmington 22
Hanoi 21
Hefei 21
Lauterbourg 17
Tokyo 17
Ho Chi Minh City 16
Princeton 15
Colorado Springs 14
Lawrence 14
Vienna 14
Turku 13
Medford 12
Buffalo 11
Seoul 11
Council Bluffs 10
Frankfurt am Main 10
Helsinki 9
Istanbul 9
Pisa 9
São Paulo 9
London 8
Ogden 8
Orem 8
Redondo Beach 8
Casablanca 7
Chicago 7
Nuremberg 7
Toronto 7
Dakar 6
Genoa 6
Rome 6
Warsaw 6
Dhaka 5
Lucca 5
Salvador 5
Stockholm 5
Baltimore 4
Boulder 4
Brooklyn 4
Denver 4
Fuzhou 4
Guarulhos 4
Haiphong 4
Johannesburg 4
Lagos 4
Macerata 4
Norwalk 4
Padova 4
Phoenix 4
Serra 4
Venice 4
Amsterdam 3
Baku 3
Biên Hòa 3
Caloocan City 3
Des Moines 3
Düsseldorf 3
Lahore 3
Mexico City 3
Montevideo 3
Piscataway 3
Recife 3
Redwood City 3
Rio de Janeiro 3
The Dalles 3
Vancouver 3
Vicenza 3
Wuhan 3
Zurich 3
Anápolis 2
Baghdad 2
Bengaluru 2
Boston 2
Brasília 2
Bucharest 2
Cairo 2
Totale 4.297
Salva come PNG Salva come JPEG
Nome #
A Clinical Tool for Prognosis and Speech Rehabilitation in Dysarthric Patients: The DESIRE Project 2.543
Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes 221
Risk factors for CIDP: antecedent events, lifestyle and dietary habits. Data from the Italian CIDP database 211
Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention 203
A novel family with axonal Charcot-Marie-Tooth disease caused by a mutation in the EGR2 gene 143
Risk Factors for Intracerebral Hemorrhage in Patients With Atrial Fibrillation on Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention 137
Exercise-Related Oxidative Stress as Mechanism to Fight Physical Dysfunction in Neuromuscular Disorders 130
Exercise therapy in muscle diseases: open issues and future perspectives 118
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study 117
E-Health & Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 3rd eNMD Congress: Pisa, Italy, 29–30 October 2021 113
Biomolecules of Muscle Fatigue in Metabolic Myopathies 109
Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy 107
Fatigue as a common signature of inflammatory myopathies: clinical aspects and care 107
Statin therapy in ischemic stroke patients with atrial fibrillation: Efficacy and safety outcomes 106
Frailties and critical issues in neuromuscular diseases highlighted by SARS-CoV-2 pandemic: how many patients are still "invisible"? 105
CSF sphingomyelin: A new biomarker of demyelination in the diagnosis and management of CIDP and GBS 99
The use of digital tools in rare neurological diseases towards a new care model: a narrative review 96
E-Health Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 1st eNMD Congress: Nice, France, March 22-23, 2019 96
Telemedicine and remote monitoring in neuromuscular diseases: Challenges and opportunities 94
Intravenous immunoglobulin in the treatment of sporadic inclusion body myositis: time for new evidence? 94
Impact of environmental factors and physical activity on disability and quality of life in CIDP 93
Post-therapy normalization of brain FDG-PET in Morvan's syndrome 85
Therapeutic opportunities and clinical outcome measures in Duchenne muscular dystrophy 79
null 74
Totale 5.280
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.517
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022136 0 4 0 8 21 18 5 4 10 8 19 39
2022/2023263 27 40 28 9 19 26 3 22 55 0 24 10
2023/20242.532 12 31 25 8 21 28 27 8 2 2.310 25 35
2024/2025823 0 32 33 46 72 62 86 52 64 85 126 165
2025/20261.206 81 165 151 139 135 88 158 60 64 96 34 35
2026/20276 6 0 0 0 0 0 0 0 0 0 0 0
Totale 5.280